Press Releases 3 Investor Relations Press Releases Events Presentations Press Releases Year None20232022202120202019201820172016 Apr 11, 2023 DermTech Announces Contract With North Carolina Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT) Apr 05, 2023 New Survey Finds Millennials and Gen Xers Not Following Safe Sun Habits, Increasing Risk of Nonmelanoma Skin Cancer Apr 03, 2023 DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 14, 2023 DermTech to Present Four New Posters and Demonstrate its Smart Stickers™ at the 2023 American Academy of Dermatology (AAD) Annual Meeting Mar 07, 2023 DermTech Adds Approximately 1.9 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT) Mar 03, 2023 DermTech to Present at March Investor Conferences Mar 02, 2023 DermTech Reports Fourth-Quarter and Full-Year 2022 Financial Results; Company Announces CEO Transition Plan Feb 10, 2023 DermTech Announces Release Date for Fourth-Quarter 2022 Financial Results Feb 09, 2023 DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by the Veterans Health Administration Jan 27, 2023 DermTech Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Next page next › Last page last » Displaying 21 - 30 of 33 Investor Tools Print Email Page Email Alerts RSS Feeds Contact IR
Press Releases Year None20232022202120202019201820172016 Apr 11, 2023 DermTech Announces Contract With North Carolina Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT) Apr 05, 2023 New Survey Finds Millennials and Gen Xers Not Following Safe Sun Habits, Increasing Risk of Nonmelanoma Skin Cancer Apr 03, 2023 DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 14, 2023 DermTech to Present Four New Posters and Demonstrate its Smart Stickers™ at the 2023 American Academy of Dermatology (AAD) Annual Meeting Mar 07, 2023 DermTech Adds Approximately 1.9 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT) Mar 03, 2023 DermTech to Present at March Investor Conferences Mar 02, 2023 DermTech Reports Fourth-Quarter and Full-Year 2022 Financial Results; Company Announces CEO Transition Plan Feb 10, 2023 DermTech Announces Release Date for Fourth-Quarter 2022 Financial Results Feb 09, 2023 DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by the Veterans Health Administration Jan 27, 2023 DermTech Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Next page next › Last page last » Displaying 21 - 30 of 33
Apr 11, 2023 DermTech Announces Contract With North Carolina Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
Apr 05, 2023 New Survey Finds Millennials and Gen Xers Not Following Safe Sun Habits, Increasing Risk of Nonmelanoma Skin Cancer
Mar 14, 2023 DermTech to Present Four New Posters and Demonstrate its Smart Stickers™ at the 2023 American Academy of Dermatology (AAD) Annual Meeting
Mar 07, 2023 DermTech Adds Approximately 1.9 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)
Mar 02, 2023 DermTech Reports Fourth-Quarter and Full-Year 2022 Financial Results; Company Announces CEO Transition Plan
Feb 09, 2023 DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by the Veterans Health Administration
